What is the CVSS score of CVE-2026-21974?

CVE-2026-21974 has a CVSS 3.1 base score of 5.3 (Medium). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N. EPSS exploitation probability: 0.0%.

Which versions of Life Sciences Central Designer are affected by CVE-2026-21974?

CVE-2026-21974 presents moderate security risk, a information exposure vulnerability rated CVSS 5.3. Sensitive information could be exposed to unauthorized parties.

How to fix or mitigate CVE-2026-21974?

Within 30 days: Identify affected systems and apply vendor patches as part of regular patch cycle. Review data exposure and access controls.

Life Sciences Central Designer CVE-2026-21974

MEDIUM

Information Exposure (CWE-200)

2026-01-20 secalert_us@oracle.com

Oracle Life Sciences Central Designer

5.3

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

5.3 MEDIUM

AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

Attack Vector

Network

Attack Complexity

Low

Privileges Required

None

User Interaction

None

Scope

Unchanged

Confidentiality

Low

Integrity

None

Availability

None

Lifecycle Timeline

Analysis Generated

Mar 12, 2026 - 21:54 vuln.today

CVE Published

Jan 20, 2026 - 22:16 nvd

MEDIUM 5.3

DescriptionCVE.org

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).

AnalysisAI

Unauthenticated attackers can read sensitive data from Oracle Life Sciences Central Designer 7.0.1.0 through an easily exploitable information disclosure vulnerability accessible via HTTP. The flaw requires no user interaction or privileges, allowing remote attackers with network access to gain unauthorized access to a subset of application data. No patch is currently available for this vulnerability.

Technical ContextAI

This vulnerability (CWE-200: Information Exposure) affects Life Sciences Central Designer. Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score